Yervoy 50 MG/10 ML vial 10ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9DW5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $30,629
Award facts
- Contract value 100% obligated
- $30,629.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $30,629.18 firm fixed price delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Yervoy (ipilimumab) 50 mg/10 ml vials. This delivery order is a child contract under AmerisourceBergen's $999.99 billion Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and extending through December 2026. The award was competitively conducted with no set-aside designation, and performance is scheduled for completion by December 23, 2025, at the company's distribution facility in Conshohocken, Pennsylvania. Yervoy is a critical immunotherapy agent used in cancer treatment, reflecting the breadth of specialty pharmaceuticals that AmerisourceBergen supplies to support military healthcare systems.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a prime vendor for federal medical procurement through the DLA's comprehensive global pharmaceutical support program. The company's extensive contract portfolio demonstrates its capability to fulfill diverse military medical supply requirements, ranging from specialty oncology medications to generic drugs, vaccines, and medical supplies across multiple therapeutic domains. Through its SPE2DX vehicle, AmerisourceBergen supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, positioning itself as a cornerstone vendor in the military medical supply chain.
Quick answers
Who was awarded contract SPE2DR26F9DW5?
SPE2DR26F9DW5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 2, 2025.
How much is contract SPE2DR26F9DW5 worth?
The government has obligated $30,629 on SPE2DR26F9DW5.
Is contract SPE2DR26F9DW5 an order under another contract?
Yes. SPE2DR26F9DW5 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9DW5 competed?
The extent of competition for SPE2DR26F9DW5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award